1 / 54

Meningitis and Encephalitis:

Meningitis and Encephalitis:. Diagnosis and Treatment Update. Definitions. Meningitis – inflammation of the meninges Encephalitis – infection of the brain parenchyma Meningoencephalitis – inflammation of brain + meninges Aseptic meningitis – inflammation of meninges with sterile CSF.

barrington
Download Presentation

Meningitis and Encephalitis:

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Meningitis and Encephalitis: Diagnosis and Treatment Update

  2. Definitions • Meningitis – inflammation of the meninges • Encephalitis – infection of the brain parenchyma • Meningoencephalitis – inflammation of brain + meninges • Aseptic meningitis – inflammation of meninges with sterile CSF

  3. Symptoms of meningitis • Fever • Altered consciousness, irritability, photophobia • Vomiting, poor appetite • Seizures 20 - 30% • Bulging fontanel 30% • Stiff neck or nuchal rigidity • Meningismus (stiff neck + Brudzinski + Kernig signs)

  4. Clinical signs of meningeal irritation

  5. Diagnosis – lumbar puncture • Contraindications: • Respiratory distress (positioning) •  ICP reported to increase risk of herniation • Cellulitis at area of tap • Bleeding disorder

  6. CSF evaluation

  7. CSF Gram stain Hemophilus influenza (H flu) Strep pneumoniae

  8. Not addressed • Indwelling CNS catheters • S/P cranial surgery • Anatomic defects predisposing to meningitis • Immunocompromised patients • Abscesses

  9. Bacterial meningitis • 3 - 8 month olds at highest risk • 66% of cases occur in children <5 years old

  10. Bacterial meningitis - Organisms • Neonates • Most caused by Group B Streptococci • E coli, enterococci, Klebsiella, Enterobacter, Samonella, Serratia, Listeria • Older infants and children • Neisseria meningitidis, S. pneumoniae, tuberculosis, H. influenzae

  11. Bacterial meningitis – Clinical course • Fever • Malaise • Vomiting • Alteration in mental status • Shock • Disseminated intravascular coagulation (DIC) • Cerebral edema • Vital signs • Level of mentation

  12. Increased intracranial pressure (ICP) • Papilledema • Cushing’s triad • Bradycardia • Hypertension • Irregular respiration • ICP monitor (not routine) • Changes in pupils

  13.  ICP treatment • 3% NaCl, 5 cc/kg over ~20 minutes • May utilize osmotherapy - if serum osms <320 • Mild hyperventilation • PaCO2 <28 may cause regional ischemia • Typically keep PaCO2 32-38 torr • Elevate HOB 30o

  14. Meningitis - Fluid management • Restore intravascular volume & perfusion • Monitor serum Na+ (osmolality, urine Na+): • If serum Na+ <135 mEq/L then fluid restrict (~2/3x), liberalize as Na+ improves • If severely hyponatremic, give 3% NaCl • SIADH • 4 - 88% in bacterial meningitis • 9 - 64% in viral meningitis • Diabetes insipidus • Cerebral salt wasting

  15. Meningitis - Treatment duration • Neonates: 14 – 21 days • Gram negative meningitis: 21 days • Pneumococcal, H flu: 10 days • Meningococcal: 7 days

  16. Bacterial Meningitis - TreatmentNeonatal (<3 mo) • Ampicillin (covers Listeria) + • Cefotaxime • High CSF levels • Less toxicity than aminoglycosides • No drug levels to follow • Not excreted in bile  not inhibit bowel flora

  17. Meningitis - Acute complications • Hydrocephalus • Subdural effusion or empyema ~30% • Stroke • Abscess • Dural sinus thrombophlebitis

  18. Bacterial meningitis - Outcomes • Neonates: ~20% mortality • Older infants and children: • <10% mortality • 33% neurologic abnormalities at discharge • 11% abnormalities 5 years later • Sensorineural hearing loss 2 - 29%

  19. Bacterial meningitis - children • Strep pneumoniae • Neisseria meningitidis • TB • Hemophilus influenza

  20. Pneumococcal meningitis

  21. Antibiotic susceptibility • Susceptible • Non-susceptible • Resistant

  22. Pneumococcal resistance • Strep pneumococcus - most common cause of invasive bacterial infections in children >2 months old • Incidence of PCN-, cefotaxime- & ceftriaxone-nonsusceptible isolates has ’d to ~40% • Strains resistant to PCN, cephalosporins, and other -lactam antibiotics often resistant to trimethoprim-sulfamethoxazole (Bactrim™, Septra™), erythromycin, chloramphenicol, tetracycline

  23. Mechanism of resistance • PCN-binding proteins synthesize peptidoglycan for new cell wall formation • PCN, cephalosporins, and other -lactam antibiotics kill S pneumoniae by binding irreversibly to PCN-binding proteins located in the bacterial cell wall • Chromosomal changes can cause the binding affinity for the -lactam antibiotics to decrease

  24. Pneumococcal meningitis – Mgmt • Vancomycin + cefotaxime or ceftriaxone, if > 1 month old • If hypersensitive (allergic) to -lactam antibiotics, use vancomycin + rifampin • D/C vancomycin once testing shows PCN-susceptibility • Consider adding rifampin if susceptible & condition not improving, or cefotaxime or ceftriaxone MIC high • Not vancomycin alone

  25. Antibiotic use inPneumococcal meningitis • PCN-susceptible organism: • PenG 250,000 - 400,000 U/kg/day  Q 4 - 6 h • Ceftriaxone 100 mg/kg/day  Q 12 - 24 h • Cefotaxime 225 - 300 mg/kg/day  Q 8 h • Chloramphenicol 50 - 100 mg/kg/day  Q 6 h • Adequate cephalosporin levels in CSF ~2.8 hours after dose administration

  26. Vancomycin use inpneumococcal meningitis • Combination therapy since late 90’s • At initiation- • Baseline urinalysis • BUN and creatinine • Enters the CSF in the presence of inflamed meninges within 3 hours • Should not be used as solo agent, but with cephalosporin for synergy

  27. Vancomycin use inpneumococcal meningitis • Vancomycin 60 mg/kg/day  Q 6 h • Trough levels immediately before 3rd dose • (10-15 mcg/mL or less) • Peak serum level 30-60 minutes after completion of a 30-minute infusion (35-40 mcg/mL)

  28. Rifampin 20 mg/kg/day  Q 12 Not a solo agent Slowly bactericidal Meropenem Carbapenem 120 mg/kg/day  Q 8 h  seizure incidence,  not generally used in meningitis Resistance reported Other antibiotics inpneumococcal meningitis (resistant)

  29. Dexamethasone use in meningitis • Consider if H flu & S pneumo meningitis & > 6 wks old 0.6 mg/kg/day  Q 6h x 2d •  local synthesis of TNF-, IL-1, PAF & prostaglandins resulting in  BBB permeability,  meningeal irritation • Debate if it  incidence of hearing loss • If used, needs to be given shortly before or at the time of antibiotic administration • May adversely affect the penetration of antibiotics into CSF

  30. Pneumococcal meningitis - Treatment • LP after 24-48 hours to evaluate therapy if: • Received dexamethasone • PCN-non-susceptible • MIC’s not available • Child’s condition not improving

  31. Infection control precautions(invasive pneumococcus) • CDC recommends Standard Precautions • Airborne, Droplet, Contact are NOT recommended • Nasopharyngeal cultures of family members and contacts is NOT recommended • No isolation of contacts • No chemoprophylaxis for contacts

  32. Meningococcal meningitis • Neisseria meningitidis • ~10 - 15% with chronic throat carriage • Outbreaks in households, high schools, dorms • Accounts for <5% of cases • 2,400 - 3,000 cases occur in the USA each year • Peaks <2 years of age & 15-24 years

  33. Meningococcal disease • Can cause purulent conjunctivitis, septic arthritis, sepsis +/- meningitis • Diagnose presence of organism (Gram negative diplococci) via: • CSF Gram stain, culture • Sputum culture • CSF (not urine) Latex agglutination • Petechial scrapings • Buffy coat Gram stain

  34. Meningococcemia - Petechiae

  35. Meningococcemia - Purpura fulminans

  36. Meningococcemia - Isolation • Capable of transmitting organism up to 24 hours after initiation of appropriate therapy • Droplet precautions x 24 hours, then no isolation • Incubation period 1 - 10 days, usually <4 days

  37. Meningococcemia - Treatment • Antibitotic resistance rare • Antibitotics: • PCN • Cefotaxime or Ceftriaxone • Patient should get rifampin prior to discharge

  38. Meningococcal disease - Care takers • Day care where child attends >25 h/wk, kids are >2 years old, & 2 cases have occurred • Day care where kids not all vaccinated • Persons who have had “intimate contact” w/ oral secretions prior & during 1st 24 h of antibiotics • “Intimate contact” – 300-800x risk (kissing, eating/ drinking utensils, mouth-to-mouth, suctioning, intubating)

  39. Meningococcemia - Prophylaxis • No randomized controlled trials of effectiveness • Treat within 24 hours of exposure • Vaccinate affected population, if outbreak

  40. Meningococcemia - Prophylaxis • Rifampin • Urine, tears, soft contact lenses orange; OCP’s ineffective • <1 mo 5 mg/kg PO Q 12 x 2 days • >1 mo 10 mg/kg (max 600 mg) PO Q 12 x 2 days • Ceftriaxone • 12 y 125 mg IM x 1 dose • >12 y 250 mg IM x 1 dose • Ciprofloxacin • 18 y 500 mg PO x 1 dose

  41. Meningococcal meningitis - Outcomes • Substantial morbidity: 11% - 9% of survivors have sequelae • Neurologic disability • Limb loss • Hearing loss • 10% case-fatality ratio for meningococcal sepsis • 1% mortality if meningitis alone

  42. TB meningitis • Children 6 months – 6 years • Local microscopic granulomas on meninges • Meningitis may present weeks to months after primary pulmonary process • CSF: • Profoundly low glucose • High protein • Acid-fast bacteria (AFB stain) • PCR • Steroids + antimicrobials

  43. Aseptic vs. partially treated bacterial meningitis • Aseptic much more common • Gram stain positive CSF: • 90 - 100% in young patients • 50 - 68% positive in older children • If CSF fails to show organisms in a pretreated patient, then very unlikely that organism is resistant

  44. Viral meningitis • Summer, fall • Severe headache • Vomiting • Fever • Stiff neck • CSF - pleocytosis (monos), NL protein, NL glucose

  45. Enteroviruses predominate Spring, summer Oral-fecal route ± initial GI symptoms Meningitic symptoms appear 7-10 days after exposure Less common: Mumps HIV Lymphocytic choriomeningitis HSV-2 Etiology viral meningitis

  46. Other causes of aseptic meningitis • Leptospira • Young adults • Late summer, fall • Conjunctivitis, splenomegaly, jaundice, rash • Exposure to animal urine • Lyme Disease (Borrelia burgdorferi) • Spring-late fall • Rash, cranial nerve involvement

  47. Viral meningitis - Treatment • Supportive • No antibiotics • Analgesia • Fever control • Often feel better after LP • No isolation - Standard precautions

  48. Viral meningitis - Outcomes • Adverse outcomes rare • Infants <1 year have higher incidence of speech & language delay

  49. Meningoencephalitis - etiology • Herpes simplex type 1 • Rabies • Arthropod-borne • St. Louis encephalitis • La Crosse encephalitis • Eastern equine encephalitis • Western equine encephalitis • West Nile

  50. Herpes simplex 1 encephalitis • Symptoms • Depressed level of consciousness • Blood tinged CSF • Temporal lobe focus on CT scan or EEG • + PCR • Neonates typically will have cutaneous vessicles • Treatment - IV acyclovir

More Related